GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...

GSK plc and the University of Oxford (Oxford) announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer ...

We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...

In oncology, GSK has been building a portfolio of “antibody drug conjugates”, a new type of chemotherapy that aims to kill cancerous cells while sparing healthy ones. Late last year ...

A high-profile team of architects, landscape designers, and consultants has been appointed to progress a masterplan for the redevelopment of the former GSK headquarters at 980 Great West Road, ...

Sustainability and joint working But Belson notes that building trust must go beyond internal projects and involve external efforts as well. He highlights GSK’s recently announced sustainability ...

He was surprised to discover, for example, that a photo of the GSK headquarters building attracted more positive comments than a story about a community partnership. A recent example of content ...

Ken Hall looks at three important considerations for investors looking to build a sizeable passive income for a better ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...